CurrentEndo — Diabetes complications

Exploring time-varying cardiovascular effects of GLP-1 receptor agonists: A multi-state network meta-analysis of cardiovascular outcome trials

2026-11-13T19:45:41.967Z

Meta-analysis · Diabetes Res Clin Pract, 2026.

The association of physical activity and sedentary behaviour with the development and progression of microvascular complications in type 1 and type 2 diabetes: A systematic review of cohort studies

2026-11-13T17:46:43.542Z

Meta-analysis · Diabetes Res Clin Pract, 2026.

Glucose variability and semen quality in young adults with type 1 diabetes using continuous glucose monitoring

2026-11-13T17:00:16.153Z

Cross-sectional study · J Clin Endocrinol Metab, 2026.

Relation of advanced cardiovascular-kidney-metabolic syndrome with mortality risk in cancer survivors: joint effect and mediating role of PhenoAge acceleration

2026-11-13T17:00:16.153Z

Cohort study · Diabetes Res Clin Pract, 2026.

Automated Prediction of Diabetes-Related Foot Ulcer Healing at Initial Assessment

2026-11-13T15:47:59.646Z

Diagnostic or prognostic study · J Diabetes Sci Technol, 2026.

Adherence to a Healthy Lifestyle in Association With Microvascular Complications Among Adults With Type 2 Diabetes

2026-11-13T11:00:06.281Z

Cohort study · JAMA Netw Open, 2023. Any microvascular complications — ≥4 low-risk factors vs 0 low-risk factors: RR 0.73 (95% CI 0.60-0.91); lifestyle before diabetes diagnosis

Cranial Nerve Affection in Adolescents with Type 1 Diabetes Assessed by Corneal Confocal Microscopy, Smell and Taste Tests

2026-11-13T10:46:56.512Z

Cross-sectional study · Pediatr Diabetes, 2023. Cranial nerve affection: Corneal confocal microscopy (CCM), smell and taste tests — T1D vs Controls; all p < 0.05; lower CCM parameters (corneal nerve fiber density, branch density, fiber length, fractal dimension) with T1D

Diabetes Complications and Cognitive Function in Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: The SEARCH for Diabetes in Youth Study

2026-11-13T10:46:56.512Z

Cohort study · Pediatr Diabetes, 2023. Age-corrected composite fluid cognition score across clusters: Average age-corrected composite fluid cognition score differed significantly across clusters in each group p<0.001

Accuracy of Foot Pressure Measurement on Predicting the Development of Foot Ulcer in Patients with Diabetes: A Systematic Review and Meta-Analysis

2026-11-13T10:44:19.723Z

Meta-analysis · J Diabetes Sci Technol, 2021. Pooled diagnostic accuracy of plantar pressure measurement (pedobarography) for ulcer development: Pooled sensitivity 0.63 (CI 0.58-0.68)

Diagnostic Accuracy of Perception Threshold Tracking in the Detection of Small Fiber Damage in Type 1 Diabetes

2026-11-13T10:44:19.723Z

Diagnostic or prognostic study · J Diabetes Sci Technol, 2023. Diagnostic accuracy of rheobase for small nerve fiber damage defined by corneal nerve fiber length (CNFL): Perception threshold tracking (rheobase): sensitivity 94%; specificity 94%; PPV 97%; NPV 89%

Home-Based Electrical Stimulation to Accelerate Wound Healing—A Double-Blinded Randomized Control Trial

2026-11-13T10:44:19.723Z

Randomized controlled trial · J Diabetes Sci Technol, 2021. Wound area, 4 weeks: IG: significant wound area reduction of 22% (baseline 7.4 ± 8.5 cm2 vs 4W 5.8 ± 8.0 cm2), P = 0.002

Impact of Albumin-to-Creatinine Ratio Point-of-Care Testing on the Diagnosis and Management of Diabetic Kidney Disease

2026-11-13T10:44:19.723Z

Cohort study · J Diabetes Sci Technol, 2021. Confirmed/suspected DKD diagnosis (all participants) 39.1%

Initial Clinical Experience with a Simple, Home System for Early Detection and Monitoring of Diabetic Foot Ulcers: The Foot Selfie

2026-11-13T10:44:19.723Z

Research article · J Diabetes Sci Technol, 2021. six months: Days with uploaded images (of eligible study days) median 76%

Repeatability, Completion Time, and Predictive Ability of Four Diabetes-Related Foot Ulcer Classification Systems

2026-11-13T10:44:19.723Z

Research article · J Diabetes Sci Technol, 2021. Inter- and intra-observer agreement (Krippendorff's α): WIfI α 0.788; intra-observer α >0.900 · UTWCS α 0.306 · SINBAD α 0.516 · Wagner α 0.374

Smart Offloading Boot System for Remote Patient Monitoring: Toward Adherence Reinforcement and Proper Physical Activity Prescription for Diabetic Foot Ulcer Patients

2026-11-13T10:44:19.723Z

Diagnostic or prognostic study · J Diabetes Sci Technol, 2022. Accuracy of real-time adherence reporting (SmartBoot vs staff observation): Average sensitivity for adherence and non-adherence 90.6%

Stratification of Microvascular Disease Severity in the Foot Using Spatial Frequency Domain Imaging

2026-11-13T10:44:19.723Z

Diagnostic or prognostic study · J Diabetes Sci Technol, 2021. Differentiation of MVD severity: SFDI: AUC (severe MVD vs diabetes only) 0.844

The NIDDK Diabetic Foot Consortium

2026-11-13T10:44:19.723Z

Research article · J Diabetes Sci Technol, 2022. NIDDK Diabetic Foot Consortium established September 2018 to facilitate high-quality clinical research on DFUs to improve healing and prevent amputations

Automated Insulin Delivery for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes with Hypoglycemia Unawareness

2026-11-13T10:42:28.137Z

Research article · Diabetes Technol Ther, 2023. Hypoglycemia exposure (CGM with actigraphy), 3 to 18 months: Hypoglycemia exposure reduced by 3 months, especially during sleep, sustained through 18 months P ≤ 0.001

Adapted Diabetes Complications Severity Index and Charlson Comorbidity Index in predicting all-cause and cause-specific mortality among patients with type 2 diabetes

2026-11-13T10:41:04.791Z

Cohort study · BMJ Open Diabetes Res Care, 2023. All-cause mortality (per score point, age- and sex-adjusted): aDCSI: HR (95% CI 1.20 to 1.21) 1.21; C-index 0.760 · CCI: HR (1.17 to 1.18) 1.18

Association of high-sensitivity C-reactive protein and diabetic nephropathy in patients with type 2 diabetes: a Mendelian randomization study

2026-11-13T10:41:04.791Z

Diagnostic or prognostic study · BMJ Open Diabetes Res Care, 2023. DN per 1-unit increase in log-transformed genetically predicted hsCRP: OR, unweighted GRS 1.80 (95% CI 1.51 to 2.14)

Evaluating the prognostic performance of bedside tests used for peripheral arterial disease diagnosis in the prediction of diabetic foot ulcer healing

2026-11-13T10:41:04.791Z

Secondary analysis · BMJ Open Diabetes Res Care, 2023. Prognostic performance for DFU healing, 12 months: Ulcers healed 52.8%

Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis

2026-11-13T10:41:04.791Z

Meta-analysis · BMJ Open Diabetes Res Care, 2023. Echocardiographic parameters: Significantly lower E/A ratio with NAFLD vs non-NAFLD

Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study

2026-11-13T10:39:51.606Z

Cohort study · Diabetes Metab, 2023. Composite DR progression: Statin plus fenofibrate 8.68 per 1,000 person-years · Statin-only 9.66 per 1,000 person-years

Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes

2026-11-13T10:39:51.606Z

Cohort study · Diabetes Metab, 2022. MAFLD vs Without MAFLD: aOR (paroxysmal supraventricular tachycardia (PSVT)) 2.04 (95% CI 1.04-4.00); adjusted for age, sex, smoking, alcohol, diabetes-related factors, comorbidities, medications, LVEF

Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease

2026-11-13T10:39:51.606Z

Cohort study · Diabetes Metab, 2022. Decline in LV systolic function — Q2 vs Q1: OR 1.22 (CI 0.88-1.68); P = 0.235

Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients

2026-11-13T10:39:51.606Z

Cohort study · Diabetes Metab, 2023. Incident events, age and sex-adjusted HR, T1DM vs T2DM — T1DM vs T2DM: HR, MI (above 60 years) 1.2; -fold

Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes

2026-11-13T10:39:51.606Z

Cohort study · Diabetes Metab, 2022. All-cause mortality (adjusted) — Any DR vs No DR: HR 1.136 (95% CI 1.054;1.224); P < 0.0001

Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate

2026-11-13T10:39:51.606Z

Cohort study · Diabetes Metab, 2023. MACE, mortality and CKD progression by DKD subtype — Alb-/eGFR+ vs Alb-/eGFR-: HR 1.42 (95% CI 1.08;1.88); MACE

Epidemiologic and clinical characteristics of diabetic foot ulcer among patients with diabetes in Afghanistan: An IDF supported initiative

2026-11-13T10:35:20.262Z

Research article · Diabetes Res Clin Pract, 2022. Proportion of DFU: Proportion of DFU 9.2%

Global estimates of diabetes-related amputations incidence in 2010–2020: A systematic review and meta-analysis

2026-11-13T10:35:20.262Z

Meta-analysis · Diabetes Res Clin Pract, 2022. IR per 100,000 individuals with diabetes: Minor amputations, IR 139.97 (95% CI 88.18-222.16)

Incidence of the first diabetic foot ulcer: A systematic review and meta-analysis

2026-11-13T10:35:20.262Z

Meta-analysis · Diabetes Res Clin Pract, 2023. Cumulative incidence of first DFU: Pooled cumulative incidence 5.65% (95% CI 4.20; 7.57)

Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China

2026-11-13T10:35:20.262Z

Cross-sectional study · Diabetes Res Clin Pract, 2023. Prevalence of PDPN: PDPN 14,699 (57.2%)

Serum Annexin A2 concentrations are increased in patients with diabetic cardiomyopathy and are linked to cardiac dysfunctions

2026-11-13T10:35:20.262Z

Cross-sectional study · Diabetes Res Clin Pract, 2022. Serum Annexin A2 concentration — DbCM vs NGR; P < 0.05; higher with DbCM

SGLT2 inhibitors reduce adverse kidney and cardiovascular events in patients with advanced diabetic kidney disease: A population-based propensity score-matched cohort study

2026-11-13T10:35:20.262Z

Cohort study · Diabetes Res Clin Pract, 2022. Kidney-related adverse events, 1 year: SGLT2i 7.7 % · Control 24.1 %

Using a contralateral shoe lift to reduce gait deterioration during an offloading fast-walk setting in diabetic peripheral neuropathy: A comparative feasibility study

2026-11-13T10:35:20.262Z

Research article · Diabetes Res Clin Pract, 2023. Both diabetes groups: minimal decreased gait speed p > 0.005

Wound healing and healing process in patients with diabetic foot ulcers: A survival analysis study

2026-11-13T10:35:20.262Z

Cohort study · Diabetes Res Clin Pract, 2023. DFU healed 56.1%

Association of type 1 diabetes and age at diagnosis of type 2 diabetes with brain volume and risk of dementia in the UK Biobank: A prospective cohort study of community‐dwelling participants

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. Incident dementia, median follow-up 11.9 years — T2D diagnosed <50 years vs Controls: HR 2.03 (95% CI 1.53-2.69); multivariable analysis; largest HR among T2D age-at-diagnosis categories

Cost‐effectiveness of guideline‐based care provision for patients with diabetes‐related foot ulcers: A modelled analysis using discrete event simulation

2026-11-13T10:31:52.844Z

Research article · Diabet Med, 2022. 3 years: All seven scenarios with higher rates of guideline-based care likely cheaper and more effective than current practice

Diabetes mellitus and the risk of post‐acute COVID‐19 hospitalizations—a nationwide cohort study

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. Post-acute hospitalization for respiratory diseases, T2D: Hospitalized with COVID-19 1515 patients (T2D) · Not hospitalized 95,887 patients (T2D)

Enablers and barriers to diabetic retinopathy eye care among first nations and Métis women

2026-11-13T10:31:52.844Z

Research article · Diabet Med, 2022. Barriers: understanding of diabetes eye care access and cost; unsupportive interactions with health care practitioners

Factors influencing diabetes‐related foot ulcer healing in Australian adults: A prospective cohort study

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. Healing of DFU (logistic regression), 6 months: Dietary supplementation: increased odds of healing (95% 1.28-14.84, p = 0.02) 4.36

Impact of case‐mix adjustment on observed variation in the healing of diabetic foot ulcers at 12 weeks using data from the National Diabetes Foot Care Audit of England and Wales: A cohort study

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. 12 weeks: Alive and ulcer-free 12,925 (47.8%)

Performance of an artificial intelligence automated system for diabetic eye screening in a large English population

2026-11-13T10:31:52.844Z

Diagnostic or prognostic study · Diabet Med, 2023. Detection of no DR vs any DR: artificial intelligence grading system: sensitivity 69.7%; specificity 92.2%

Reduction in the prevalence of methicillin‐resistant Staphylococcus aureus in tissue and wound swab samples taken from outpatients attending a specialist diabetic foot clinic 2005–2021

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2023. Annual MRSA DFU prevalence: Peak in 2008 14.6% (n = 38)

Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries

2026-11-13T10:28:29.610Z

Cohort study · Cardiovasc Diabetol, 2023. MACE, mean 34 months: SHR1 15.4% · SHR2 16.8% · SHR3 35.3%

Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance

2026-11-13T10:28:29.610Z

Cross-sectional study · Cardiovasc Diabetol, 2023. Myocardial MEEi: I tertile 0.31 ± 0.05 ml/s*g · III tertile 0.42 ± 0.14 ml/s*g

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide cohort study

2026-11-13T10:28:29.610Z

Cohort study · Cardiovasc Diabetol, 2023. Stroke, 4.0 (IQR 2.5-6.2) years' follow-up — Group 4 vs Group 1: HR 0.58 (95% CI 0.51-0.67); p < 0.001; lowest risk of stroke

The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease

2026-11-13T10:28:29.610Z

Cohort study · Cardiovasc Diabetol, 2023. Composite cardiovascular events, mean follow-up 2.1 years: GLP-1RAs 78 (13%) · DPP-4is 204 (13.8%)

Associations of microvascular complications with all‐cause death in patients with diabetes and COVID ‐19: The CORONADO , ABCD COVID‐19 UK national audit and AMERICADO study groups

2026-11-13T10:20:05.638Z

Meta-analysis · Diabetes Obes Metab, 2022. All-cause death during hospital stay, meta-analysis of 3 studies — Microvascular complications vs Free of complications: unadjusted OR 2.05 (95% CI 1.42-2.97)

Global mortality of diabetic foot ulcer: A systematic review and meta‐analysis of observational studies

2026-11-13T10:20:05.638Z

Meta-analysis · Diabetes Obes Metab, 2022. Kaplan-Meier-based survival rates: Survival at 1 year 86.9% (95% CI 82.6%-91.5%)